Exosome engineering in cell therapy and drug delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Cell Biology

Background:

• Cell-derived exosomes possess unique properties like low immunogenicity and tissue penetration, making them promising for advanced therapies.
• Exosomes are explored for liquid biopsy in disease diagnosis and prognosis.
• Current clinical applications of exosomes are limited by challenges in large-scale production, circulation stability, and targeting efficiency.

Purpose of the Study:

• To comprehensively review novel bioengineering techniques for exosome development.
• To analyze the merits and drawbacks of various exosome engineering approaches.
• To discuss strategies for enhancing exosome circulation time, targeting capacity, and drug loading/delivery efficacy.

Main Methods:

• Review of existing literature on exosome bioengineering.
• Analysis of different engineering strategies to improve exosome characteristics.
• Evaluation of methods for large-scale exosome production and therapeutic refinement.

Main Results:

• Bioengineering offers solutions to enhance exosome therapeutic potential by improving circulation stability and targeting.
• Various techniques are being developed to refine exosome drug loading and delivery efficiencies.
• Significant progress in exosome engineering is paving the way for new diagnostic platforms and therapeutic strategies.

Conclusions:

• Exosome bioengineering is essential for overcoming current limitations and realizing their full therapeutic potential.
• Further advancements in engineering approaches will drive the clinical translation of exosome-based therapies and diagnostics.
• Continued research into exosome engineering is critical for developing effective and safe cell-derived nanovesicle therapeutics.